Lilly Cuts Price of Zepbound Vials to Battle Cheaper Copies (1)

Eli Lilly & Co. is ramping up the fight against cheaper, copycat versions of Zepbound by lowering prices for a version of its blockbuster obesity drug.

The company is reducing the cost of its 2.5 milligram and 5 milligram Zepbound vials to $349 and $499 a month, respectively, according to a statement. That’s about $50 less than current prices.

Patients who don’t have insurance coverage for weight-loss drugs, including those on Medicare, are turning to vials because they are about half the list price of the standard, injector-pen version. These cheaper options have a trade-off, though, with users needing ...